Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
NEAR Holds Attention as Several Analysts Observe Bullish Tendencies on the Altcoin’s Price Chart

NEAR Holds Attention as Several Analysts Observe Bullish Tendencies on the Altcoin’s Price Chart

CryptonewslandCryptonewsland2026/07/30 13:48
By:Cryptonewsland
  • NEAR holds attention as several analysts observe bullish tendencies. 
  • Altcoin NEAR may be dipping one final fall before a parabolic shift. 
  • NEAR could dip as low as the $1.2 price range before surging back up.

As we move towards a new month, many analysts continue to share positive and bullish indicators across multiple altcoin price charts. At the moment, it is not only the pioneer altcoin asset, Ethereum (ETH), that holds investor attention, but also other promising altcoins like NEAR and XRP. Specifically, NEAR holds attention as several analysts observe bullish tendencies on the altcoin’s price chart.

NEAR Holds Attention as Several Analysts Observe Bullish Tendencies 

While the price of ETH continues to hold at the $1,900 price range, many experts notice how the asset is struggling to climb back up over the $2,000 price range. This has led to many experts calling for the final leg down leading to bear market bottom prices over the coming days. With BTC expected to fall as low as the $54,000 price range, altcoins will likely follow and set their own bottom targets. 

$NEAR ✍🏻

NEAR has finally reached the area we've been waiting for over the past few weeks.

If you zoom out to the Daily, 3D, and Weekly charts, you'll notice something important: price has already lost multiple key trendlines and support levels. That tells me the market… https://t.co/mWdPmssTXL pic.twitter.com/ywspbkxDDc

— @KhonshuArc (@KhonshuArc) July 29, 2026

Already altcoins like ETH and XRP seem to be preparing for the final fall and the analyst in the post above believes NEAR will move right alongside them. In detail, he marks how NEAR has finally reached the area we’ve been waiting for over the past few weeks. If one would zoom out to the Daily, 3D, and Weekly charts, they will notice something important, that the price of NEAR has already lost multiple key trend lines and support levels.

That tells us that the market structure has shifted, and that the asset is now trading at a critical point. Thus, the expert states that NEAR needs to reclaim the $1.65 – $1.70 price range, and if it fails to reclaim this, then the asset could head towards the $1.25 – $1.35 price range instead. If that area fails to attract buyers, perhaps even a retest to the weekly swing low around $0.84 is likely later in the cycle. 

Several Altcoins Show Major Pump Potential 

However, on the upside, he says the only moment to chase NEAR is if the asset reclaims the $1.85 – $1.90 price range. Even then, the real test sits around $2.10 – $2.20, where multiple higher-timeframe moving averages are waiting. One thing he encourages traders to do is to find encouragement in the Daily, 3D, and Weekly RSI, which are all becoming increasingly stretched. That tells us that NEAR is getting closer to an exhaustion point.

$NEAR ✍️🏻

NEAR has played out beautifully, exactly the way we mapped it. As I mentioned in my previous update, I didn't like the structure, and that weakness is exactly what we've seen.

Now we're sitting at the most important zone on the chart: $1.70-$1.80.

This is where buyers… https://t.co/vfC6gi4Gnv pic.twitter.com/JRxW733Y7O

— @KhonshuArc (@KhonshuArc) July 26, 2026

Having said that, he confirms that being oversold doesn’t mean a reversal will play out next. In conclusion, this is where patience matters most, as the next move from this region will likely determine whether NEAR starts building a higher-timeframe base or extends its correction into the next major demand zone. On the fundamental side, NEAR continues to build. The recent mainnet upgrade and ongoing ecosystem development are positive long-term catalysts, but in the short term, price action always comes first.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Phase III trial failure for new heart drug causes Novo Nordisk shares to plunge: increasing reliance on weight-loss drugs, R&D transformation faces new test

Novo Nordisk announced on Friday that its cardiovascular drug ziltivekimab failed to reduce the risk of major cardiovascular events in a phase III clinical trial involving 6,300 patients, causing its stock price to plummet by 8.7% in a single day. The market had held high expectations for ziltivekimab, hoping the drug would establish a second growth curve beyond diabetes and weight-loss medications.

华尔街见闻2026/07/31 22:26